Publications by authors named "Ashraf Tabll"

Claim this Profile
I
Insights into antiviral activity of chlorpromazine against RNA viruses: Molecular docking, ADME profile, and semi-in vivo study.
Thoria Donia, Samar S Alkafaas, Doha F Ismail, Eiman Adly, Ashraf A Tabll

J Virol Methods· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A virus-like-particle-producing DNA vaccine triggers specific humoral immunity against hepatitis C virus in mice.
Nahla A Hussein, Rasha A M Azouz, Reem El-Shenawy, Naiera M Helmy, Ashraf A Tabll

Arch Virol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches.
Sherif A El-Kafrawy, Mostafa S Elkafrawy, Esam I Azhar, Anwaar Saeed, Ashraf A Tabll

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals.
Mohamed A Abdelrazek, Ahmed I Elghwab, Ashraf A Tabll, Elsherbiny H Elsayed, Mohammed El Behery

World J Virol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OPTIMIZATION OF HCV CELL CULTURE SYSTEM FOR EVALUATION OF ANTIVIRAL DRUGS AGAINST HCV GENOTYPES 2a AND 4a.
Naiera M Helmy, Reem El-Shenawy, Tawfeek H Abdelhafez, Ashraf A Tabll, Ana Petrović

Acta Clin Croat· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development.
Ahmed A Ali, Ashraf A Tabll

Virology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt.
Ahmed A Ali, Rasha A M Azouz, Nahla A Hussein, Reem El-Shenawy, Naiera M Helmy, Ashraf A Tabll

BMC Biotechnol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.
Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy, Yasmine S El-Abd, Ashraf A Tabll

Virol J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.
Heba Shawky, Ashraf A Tabll, Reem M Elshenawy, Naiera M Helmy, Rehab I Moustafa

Microb Cell Fact· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum collagen IV as a predictor for response to direct-acting antivirals hepatitis C therapy.
Mohammed El Behery, AhmedI Elghwab, Ashraf A Tabll, Elsherbiny H Elsayed, Mohamed A Abdelrazek

J Immunoassay Immunochem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.
Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy, Yasmine S El-Abd, Ashraf A Tabll

Virol J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum thymosin beta 10 level as a potential prognosis prediction of hepatocellular carcinoma and hepatic diseases.
Faten M Zahran, Arwa I El Ksass, Ashraf A Tabll

Egypt J Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Interleukin 6 and Interleukin 8 in Response to Treatment of Hepatitis C Virus.
Marwa A Kodous, Ashraf A Tabll, Elsherbiny H Elsayed, Mohammed El Behery, Mohamed A Abdelrazek

Clin Lab· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model.
Marija Hefer, Ana Petrovic, Lucija Kuna Roguljic, Tea Omanovic Kolaric, Tomislav Kizivat, Ashraf A Tabll

Curr Issues Mol Biol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of three novel mouse monoclonal antibodies targeting spike protein S1 subunit of Middle East respiratory syndrome corona virus.
Aymn T Abbas, Sherif A El-Kafrawy, Ashraf A Tabll, Anwar M Hashem, Tagreed L Al Subhi

Hum Antibodies· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity study of a Novel DNA-Based HCV vaccine candidate.
Eman A Salem, Ashraf Tabll, Tamer Z Salem, Yasmine S El-Abd, Reem El-Shenawy

Egypt J Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal IgY antibodies: advancements and limitations for immunodiagnosis and immunotherapy applications.
Ashraf A Tabll, Yasser E Shahein, Mohamed M Omran, Nahla A Hussein, Asmaa El-Shershaby

Ther Adv Vaccines Immunother· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer.
Mohamed M Omran, Manar S Fouda, Sara A Mekkawy, Ashraf A Tabll, Ahmed G Abdelaziz

Technol Cancer Res Treat· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of viral hepatitis (A, B, C, and E) infection and co-infection among hospitalized children in Cairo, Egypt.
Enas Mostafa, Reem El-Shenawy, Ashraf Tabll, Sahar Shoman

Egypt J Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.
Heba Shawky, Ashraf A Tabll, Reem M Elshenawy, Naiera M Helmy, Rehab I Moustafa

Microb Cell Fact· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future Prospects, Approaches, and the Government's Role in the Development of a Hepatitis C Virus Vaccine.
Ashraf A Tabll, Sayed S Sohrab, Ahmed A Ali, Ana Petrovic, Sabina Steiner Srdarevic

Pathogens· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update.
Kristina Bojanic, Mirta Sudaric Bogojevic, Sonja Vukadin, Renata Sikora, Gordana Ivanac, Ashraf A Tabll

J Clin Transl Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative assessment of homemade ELISA and lateral flow assay (LFA)in the rapid, specific and sensitive detection of SARS-CoV-2 anti-nucleocapsid protein in sera of Egyptian patients.
Asmaa El-Shershaby, Nahla Hussein, Esraa Ali, Amr El-Hakim, Ashraf Tabll

J Immunoassay Immunochem· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis.
Mona A Omar, Mohamed M Omran, Khaled Farid, Ashraf A Tabll, Yasser E Shahein

Biomedicines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2?
Mohamed Hessien, Thoria Donia, Ashraf A Tabll, Eiman Adly, Tawfeek H Abdelhafez

Viruses· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis